Sigyn Therapeutics (QB) Stock Price

0.001561 (1.07%)
Volume 400
Bid Price 0.1461
Ask Price 0.2489
News -
Day High 0.147561


52 Week Range


Day Low 0.1461
Best deals to access real time data!
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Small Cap Pro
Monthly Subscription
for only
Ultimate Trader (Monthly)
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Sigyn Therapeutics Inc (QB) SIGY OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
0.001561 1.07% 0.147561 15:30:03
Open Price Low Price High Price Close Price Prev Close
0.1461 0.1461 0.147561 0.147561 0.146
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
2 400 $ 0.1461 $ 58 - 0.146 - 1.015
Last Trade Time Type Quantity Stock Price Currency
09:59:23 200 $ 0.147561 USD


Draw Mode:

Sigyn Therapeutics Inc (QB) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 5.50M 37.30M 8.63M $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
1.60k $ - - - -

more financials information »

Sigyn Therapeutics (QB) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical SIGY Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.1460.1475610.1460.1461000.001561.07%
1 Month0.1460.2680.1460.25668654,2530.001561.07%
3 Months0.2610.3490.1460.21179565,580-0.11344-43.46%
6 Months0.41750.49750.1460.30706224,581-0.26994-64.66%
1 Year1.001.0150.1460.47734764,179-0.85244-85.24%
3 Years1.85013.500.1461.063,290-1.70-92.02%
5 Years1.85013.500.1461.063,290-1.70-92.02%

Sigyn Therapeutics (QB) Description

Sigyn Therapeutics, Inc, is a development-stage therapeutic technology company headquartered in San Diego, California USA. Our focus is directed toward a significant unmet need in global health; the treatment of life-threatening inflammatory conditions that are precipitated by Cytokine Storm Syndrome and not addressed with an approved therapy. Our mission is to save lives. Sigyn Therapy is a novel blood purification technology designed to mitigate cytokine storm syndrome through the broad-spectrum depletion of inflammatory targets from the bloodstream. Cytokine storm syndrome is the hallmark of sepsis, which is the most common cause of in-hospital deaths and claims more lives each year than all forms of cancer combined. Virus induced cytokine storm (VICS) is associated with high mortality and is a leading cause of SARS-CoV-2 (COVID-19) deaths. Other therapeutic opportunities include, but are not limited to bacteria induced cytokine storm (BICS), acute respiratory distress syndrome (ARDS) and acute forms of liver failure, such as hepatic encephalopathy.

Your Recent History
Sigyn Ther..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now